Molecularinstruments
1 known investors
Molecular Instruments develops HCR-based in situ hybridization and immunofluorescence products for detecting and quantifying RNA and protein targets in biological samples. Its enzyme-free signal amplification technology supports multiplex RNA-FISH and same-species antibody immunofluorescence for life science researchers.
BiotechHardwareMedical Devices